The gene therapy market landscape has transformed significantly since the approval of the world's first gene therapy, Gendicine®, in the early 2000's. Ever since then, with the constant R&D efforts of the gene therapy companies and non-industry stakeholder, an increasing number of therapies have entered the gene therapy market.
